Detalhe da pesquisa
1.
Mortality in older adults following a fragility fracture: real-world retrospective matched-cohort study in Ontario.
BMC Musculoskelet Disord
; 22(1): 105, 2021 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485305
2.
Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada.
BMC Musculoskelet Disord
; 22(1): 224, 2021 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33637078
3.
A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.
Support Care Cancer
; 26(1): 7-20, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28939926
4.
NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim.
Support Care Cancer
; 26(4): 1323-1334, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29147854
5.
A Randomized, Single-Blind Study Evaluating the Effect of a Bone Pain Education Video on Reported Bone Pain in Patients with Breast Cancer Receiving Chemotherapy and Pegfilgrastim.
Pain Manag Nurs
; 19(6): 693-706, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29935909
6.
The effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic review.
Support Care Cancer
; 25(8): 2619-2629, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28484882
7.
Burden of Chemotherapy-Induced Febrile Neutropenia Hospitalizations in US Clinical Practice, by Use and Patterns of Prophylaxis with Colony-Stimulating Factor.
Support Care Cancer
; 25(2): 439-447, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27734153
8.
Relationship between severity and duration of chemotherapy-induced neutropenia and risk of infection among patients with nonmyeloid malignancies.
Support Care Cancer
; 24(10): 4377-83, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27278272
9.
Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis in US clinical practice.
Support Care Cancer
; 24(6): 2481-90, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26670915
10.
Comorbidities among patients with cancer who do and do not develop febrile neutropenia during the first chemotherapy cycle.
J Oncol Pharm Pract
; 22(5): 679-89, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26378158
11.
Importance of Risk Factors for Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified as High-Risk in Guidelines for Myeloid Growth Factor Use.
J Natl Compr Canc Netw
; 13(8): 979-86, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26285243
12.
Protocol adherence and the progression of cardiovascular calcification in the ADVANCE study.
Nephrol Dial Transplant
; 28(1): 146-52, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23028103
13.
Presence of valvular calcification predicts the response to cinacalcet: data from the ADVANCE study.
J Heart Valve Dis
; 22(3): 391-9, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24151766
14.
A retrospective observational study of osteoporosis management after a fragility fracture in primary care.
Arch Osteoporos
; 17(1): 75, 2022 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513573
15.
Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study.
CJC Open
; 4(6): 558-567, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734519
16.
Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab alone.
Clin Colorectal Cancer
; 7(3): 184-90, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18621636
17.
Performance of the pegfilgrastim on-body injector as studied with placebo buffer in healthy volunteers.
Curr Med Res Opin
; 33(2): 379-384, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27819161
18.
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES).
Clin Colorectal Cancer
; 16(2): 103-114.e3, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28038865
19.
Metaplastic breast cancer: clinical significance.
Am J Surg
; 191(5): 657-64, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16647355
20.
Annual patient and caregiver burden of oncology clinic visits for granulocyte-colony stimulating factor therapy in the US.
J Med Econ
; 19(5): 537-47, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26745764